Skip to main content

Job as Group Leader, Scientist, Engineer in Teva API India Pvt. Ltd.

TAPI is the leading international supplier of active pharmaceutical ingredients (APIs). With the industry’s broadest portfolio of over 300 API products, TAPI achieved third-party sales of some $724 million in 2014. A standalone unit within Teva Pharmaceutical Industries, TAPI’s history in the generic API industry dates back over 75 years. Headquartered in Israel, next to Tel Aviv, TAPI employs more than 5,000 professionals at over 20 sites worldwide. TAPI’s state-of-the-art production facilities are located in Italy, Hungary, the Czech Republic, Croatia, Israel, India, China, Mexico, Puerto Rico and the United States.

Post: Group Leader, Scientist, Engineer

Required for Physiotherapist in Raje Healthcare

We are a retail chain that provides high quality medical products and services, Our customer focus provides an engaging and fulfilling buying experience for our customers. We provide customer delight through innovative processes intuitive customer service operational excellence technological competence enthusiastic and informed employees

Post: Physiotherapist

Platform Technology Scientist For Natural Product Research Platform in RGCB

NPRP seeks to identify bioactive compounds with therapeutic and agronomic value. Ayurveda, India’s traditional medicine culture and knowledge inspires this program that investigates compounds from plants, fungi and many other living organisms. Our aim is to develop innovative pharmaceutical products and dietary supplements that may alleviate the public health burden caused by chronic diseases as well as infectious diseases particularly circumvention of drug resistance. In addition the program also has keen interest in developing natural products with agronomic importance such as bio-pesticides. NPRP will have the support from RGCB’s excellent infrastructure in genomics, cell & molecular biology, metabolomics, proteomics, chemoinformatics as well as the excellent pilot process plant located at BioNest, RGCB’s third campus at Kochi. NPRP will strive to develop validated analytical & separation technology, synthesis of analogs, activity guided fractionation, bioactivity assays using newer cellular assays & animal models, structural characterization of new bio-active compounds, down stream processing and formulation. The primary location of work will be at the RGCB’s Innovation Center in Thiruvananthapuram and BioNest Campus at Kochi.

Post: Platform Technology Scientist (Institute Plan Project Position at Cost to Company basis)

Walk in interview for B.Sc/ B.Pharm/ M.Pharm/ M.Sc in QC department in Rubicon Research

Rubicon Research is a pioneer Drug Delivery Technology company and is recognized as a world, class outsourcing partner in the pharmaceutical industry

Post: Walk In Interview-Quality Control Department

Required for Stability Specialist in Novartis

A global healthcare leader, Novartis has one of the most exciting product pipelines in the industry today. A pipeline of innovative medicines brought to life by diverse, talented and performance driven people. All of which makes them one of the most rewarding employers in their field.

Post: Stability Specialist

Walk in for B.Pharm/M.Pharm as Resource Person on Extension Lecture (5 Posts) in MDU

Maharshi Dayanand University, ab initio established as Rohtak University, Rohtak, came into existence by an Act No. 25 of 1975 of the Haryana Legislative Assembly in 1976 with the objective to promote inter-disciplinary higher education and research in the fields of environmental, ecological and life sciences. It was rechristened as Maharshi Dayanand University in 1977 after the name of a great visionary and social reformer, Maharshi Dayanand. It had a unitary and residential character in its nascent stage, but became an affiliating University in November 1978. The University secured the recognition of University Grants Commission – the higher education regulatory body of India - for central Govt. grants in Feb. 1983.

Post: Resource Person on Extension Lecture

Pharmchem invites Production Chemist, Production engineer | 7 Posts

We are WHO-GMP certified manufacturers of APIs/ Bulk Drug in pharmaceutical industry and exporting to more than 33 countries. We are established since 1973. The Company has well established pl manufacturing plant at Bahadurgarh- Haryana Our sheer hard work and quality Consciousness has helped PHARMCHEM to achieve a commendable position in the world market of APIs. Today PHARMCHEM is ranked among the top five manufacturers of Erythromycin salts and is second largest manufacturers of silver sulphide.Our endeavour is to get recognition in the Global Health Market as a dependable and fast growing Organization. Azithromycin/Erythromycin Estolate/Ofloxacin/Mefanamic acid/Erythromycin stearate etc

Post: Production Chemist, Production engineer

Work as Executive- IT in Akcent healthcare

Akcent healthcare is India’s most upcoming fastest growing pharmaceuticals & marketing organization bases in the heart of India( DELHI) the capital of INDIA. Making the best products available to our patient is our prime objective and we are determined to provide the best of services to our patient and associates through highly professional and motivated team. We believe that we are one of the leading players in the pharmaceuticals formulation market in India.

Post: Executive- IT

STUDY OF EFFECT OF SUPPLEMENTATION OF ZINGIBER OFFICINALE ON PHARMACOKINETIC PROFILE OF SITAGLIPTIN PHOSPHATE ON STREPTOZOTOCIN INDUCED TYPE II DM RAT MODEL

{ DOWNLOAD AS PDF }

ABOUT AUTHORS:
Swati R. Dhande, Aruhana R. Patil*, Lilasrao J. Kadam
Bharati Vidyapeeth's College of Pharmacy,
Belapur, Navi Mumbai
*arpatil1991@gmail.com

ABSTRACT
Diabetes Mellitus (DM) is a metabolic endocrine disorder. It is one of the most rapidly growing diseases worldwide. Various pharmacotherapies have been practiced in the cure and management of DM. The existing conventional therapies aims at reducing hyperglycemia and achieving better glycemic control over the time, but fail to combat the other risk factors associated with the disease. The newer approaches are targeting to combat the risk factors and reduce the progression of disease. The newer approaches includes regenerational therapies, use of herbal and natural supplements, use of antioxidants and use combinations of conventional therapies with above mentioned therapies. Though these combinations have been found to be promising in the management of DM, the risk of pharmacological interactions cannot be overlooked. The present study was conducted to evaluate the pharmacokinetic interaction between DPP-IV inhibitor sitagliptin and a nutraceutical Z. officinale. STZ (Streptozotocin) and HFD (High Fat Diet) induced Type II DM rat model was used and the possible interaction was determined. The evaluation was done on validated HPTLC bioanalytical method. The present combination of sitagliptin and ginger did not affect the pharmacokinetic profile of sitagliptin.

Recruitment for Clinical Research Associate in Sai Clinical Research Institute | 5 Posts

Sai CRI is a Chennai based Indian organization, provider of International Clinical Research Education and Job Placement Support for medical or life science professionals, interested to enter the rewarding field of clinical trial administration and management.
It was established to provide affordable CRP (Clinical Research Professional) certification training, combined with practical internship and job insertion and placement assistance, a very needed active service, not offered by other providers, and to create jobs and job opportunities for its members.

Post: Clinical Research Associate

Career as Operation Specialist in Quintiles

Quintiles is the only fully integrated biopharmaceutical services company offering clinical, commercial, consulting and capital solutions worldwide. Our network of 23,000 engaged professionals in 60 countries around the globe works with an unwavering commitment to patients, safety and ethics — ensuring a higher level of healthcare for people. For our biopharmaceutical customers, we help them navigate risk and seize opportunities in an environment where change is constant.
Quintiles is consistently cited as the most favored contract research organization (CRO) in independent surveys of the bio pharma industry and was recently named “2009 CRO of the Year” by the prestigious SCRIP Awards.

Post: Operations Specialist-1514699

Dr. B.C Roy College of Pharmacy & Allied Health Sciences, Durgapur is looking for Professors & Associate Professor

Increased life expectancy coupled with ever-growing rate of literacy and higher income level, have raised the higher demand for quality treatment warranting a sound support system for the health care system. With advancement in medical sciences and concomitant growing demand for qualified and trained personnel in Pharmacy, need for well-qualified industry-ready bright Pharmacy graduates is being felt like never before, more so in West Bengal.
To meet the situation, the entrepreneurs associated with Dr. B. C. Roy Group of Colleges, with support from like-minded professionals founded Dr. B. C. Roy College of Pharmacy and Allied Health Sciences in September, 2005 at the centre of Durgapur Steel City on aroun four acres of Govt. land procured from ADDA, Govt. of West Bengal.

Post: Professors & Associate Professor

Opening for Clinical Data Analyst in Novartis

A global healthcare leader, Novartis has one of the most exciting product pipelines in the industry today. A pipeline of innovative medicines brought to life by diverse, talented and performance driven people. All of which makes them one of the most rewarding employers in their field.

Post: Clinical Data Analyst

Roche announced that in the large pivotal Phase II study, BIRCH, the investigational cancer immunotherapy atezolizumab (MPDL3280A; anti-PDL1) met its primary endpoint and shrank tumours (objective response rate; ORR) in people with locally advanced or metastatic non-small cell lung cancer (NSCLC) whose disease expressed PD-L1 (Programmed Death Ligand-1). The study showed the amount of PD-L1 expressed by a person’s cancer correlated with their response to the medicine. Adverse events were consistent with what has been previously observed for atezolizumab.

Researchers found that a new combination therapy was highly effective at treating patients with melanoma, which is known as the most serious type of skin cancer. The findings were published online in the Journal of the American Academy of Dermatology.

Nearly 30 per cent of all liver for transplantation is rejected because the donors have 'fatty livers', a disease which is likely to increase in future, the government said. Minister of State for Health Shripad Naik said that the prevalence of non-alcoholic fatty liver disease (NAFLD) is considered to be a known cause of rejection for liver transplantation because of accumulation of fat in the liver.

Job as Clinical Research Associate at HLL Corporate R&D centre - Enterprise under the Ministry of Health & Family Welfare, Govt. of India

HLL Lifecare Limited, a Mini Ratna Central Public Sector Enterprise under the Ministry of Health & Family Welfare, Govt. of India is a global provider of high quality healthcare products & services. With state-of-the-art  manufacturing facilities spanning across India, HLL is diversifying into vaccine manufacturing, lifecare services, sanitary napkins besides engaging in procurement consultancy, healthcare infrastructure development and facility management.

Post: Clinical Research Associate

INSPIRE FELLOWSHIP FOR PURSUING DOCTORAL PROGRAMME IN SCIENCE & PHARMACY

Innovation in Science Pursuit for Inspired Research (INSPIRE) is being implemented by the Department of Science & Technology (DST) to strengthen the National Science and Technology base. One Component of the AORC Scheme in INSPIRE is focused on attraction of student to pursue doctoral degree in basic and applied sciences including engineering, medicine, agriculture, veterinary, pharmacy etc. after either masters’ degree in Science/ Applied Science/ Engineering or bachelor/ masters’ degree in Medicine.

Vacancy for Research Assistant in Motilal Nehru National Institute of Technology

Applications are invited from Indian nationals for the post of Research Assistant (on contract) in research project entitled “Design and Innovation Centre” F.No.17-2-2014-PN.1(Vol. II) dated 20-1-2015 sponsored by Ministry of Human Resource Development, GOI, New Delhi. The duly completed application on prescribed format along with copies of supporting documents must reach to: Office of the Dean (Research & Consultancy), Motilal Nehru National Institute of Technology, Allahabad-211004 on or before 28/08/2015. The envelope should be super scribed as “Application for the post of Research Assistant (on contract) in the Project “Design and Innovation Centre”. A soft copy of the application should also be sent to shiveshs@mnnit.ac.in email address of Dr. Shivesh Sharma. The position is purely temporary and will be governed by the funding agency rules & service conditions of Office of the Dean (Research & Consultancy), MNNIT Allahabad.

Post: Research Assistant

Job for B.Pharm/M.Pharm as Sr. Executive/ Executive Regulatory Affairs in Aurolab - candidates from TN & AP preferred

Aurolab, based in southern part of India, is an integral part of the Aravind Eye Care System. It manufactures a wide range of high quality ophthalmic consumables such as intraocular lenses, surgical sutures, pharmaceutical products, surgical blades and equipments.

Post: Sr. Executive/ Executive Regulatory Affairs

Subscribe to